SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-04-036476
Filing Date
2004-03-09
Accepted
2004-03-08 17:37:01
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO FORM S-1 ds1a.htm S-1/A 1785269
3 2003 EMPLOYEE STOCK PURCHASE PLAN dex1031.htm EX-10.31 86907
4 COLLABORATION AGREEMENT WITH FRESENIUS BIOTECH GMBH, DATED NOVEMBER 14, 2003 dex1048.htm EX-10.48 253842
5 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.htm EX-23.1 1693
7 GRAPHIC g26071g14o31.jpg GRAPHIC 119538
8 GRAPHIC g26071g68b48.jpg GRAPHIC 104138
9 GRAPHIC g26071g85j06.jpg GRAPHIC 35214
10 GRAPHIC g26071g93g78.jpg GRAPHIC 114916
11 GRAPHIC g26071g99y74.jpg GRAPHIC 27368
  Complete submission text file 0001193125-04-036476.txt   2531256
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-109653 | Film No.: 04655582
SIC: 2834 Pharmaceutical Preparations